Phase 1 Study of TAK-831 in Healthy Adult Asian Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Takeda
Related studies linked through entity extraction aliases.
IPD in RRMM Characterized with Genomic Abnormalities of Adverse Prognostic
- Status
- TERMINATED
- Phase
- PHASE2
Wearable Assessments in the Clinic and Home in PD
- Status
- COMPLETED
- Phase
- N/A
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
- Status
- COMPLETED
- Phase
- N/A
A Study to Describe Pain Intensity, Pain Relief and Safety of Neosaldina in the Treatment of Tension-type Headaches (TTH) in Healthy Participants
- Status
- COMPLETED
- Phase
- N/A
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Soticlestat in Adults and Children With Rare Epilepsies
- Status
- TERMINATED
- Phase
- PHASE2
Agrylin Drug Use-Result Survey
- Status
- COMPLETED
- Phase
- N/A
Survey Study for Velaglucerase Alfa (VPRIV) in Japan
- Status
- COMPLETED
- Phase
- N/A
Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma
- Status
- COMPLETED
- Phase
- N/A
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004
- Status
- COMPLETED
- Phase
- PHASE3
Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes
- Status
- WITHDRAWN
- Phase
- PHASE4
BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2